Interleukin-10 does not affect IL-1-induced interleukin-6 and metalloproteinase production in human chondrosarcoma cells, SW1353

International Journal of Molecular Medicine

Volumn 17, Issue 2, 2006, Pages 377-383

  Radons, Jürgen ^a   Falk, Werner ^b   Schubert, Thomas E O ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Chondrocytes; IL 10; IL 10 receptor; IL 6; Metalloproteinases; STAT3; SW1353

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN RECEPTOR; METALLOPROTEINASE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHONDROSARCOMA; CLASSIFICATION; DOWN REGULATION; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MACROPHAGE; METABOLISM; MOUSE; SECRETION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CHONDROSARCOMA; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MACROPHAGES; METALLOPROTEASES; MICE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10; STAT3 TRANSCRIPTION FACTOR;

EID: 33644864148     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.17.2.377     Document Type: Article

References (41)

1. Curl WW, Krome J, Gordon ES, Rushing J, Smith BP and Poehling GG: Cartilage injuries: a review of 31,516 knee arthroscopies. Arthroscopy 13: 456-460, 1997.
2. Steadman JR, Rodkey WG, Briggs KK and Rodrigo JJ: The microfracture technique to treat full thickness articular cartilage defects of the knee. Orthopade 28: 26-32, 1999.
3. Steadman JR, Rodkey WG and Briggs KK: Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation, and outcomes. Am J Knee Surg 15: 170-176, 2003.
4. Bert JM: Abrasion arthroplasty. Oper Tech Orthop 4: 294-299, 1997.
5. Newman AP: Articular cartilage repair. Am J Sports Med 26: 309-324, 1998.
6. Garrett JC: Osteochondral allografts for reconstruction of articular defects of the knee. Instr Course Lect 47: 517-522, 1998.
7. Kish G, Modis L and Hangody L: Osteochondral mosaicplasty for the treatment of focal chondral and osteochondral lesions of the knee and talus in the athlete. Clin Sports Med 18: 45-66, 1999.
8. Minas T and Peterson L: Advanced techniques in autologous chondrocyte transplantation. Clin Sports Med 18: 13-16, 1999.
9. Minas T: The role of cartilage repair techniques, including chondrocyte transplantation, in focal chondral knee damage. Instr Course Lect 48: 629-643, 1999.
10. Grütz G: New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 77: 3-15, 2005. (Pubitemid 40310687)
11. Williams LM, Ricchetti G, Sarma U, Smallie T and Foxwell BM: Interleukin-10 suppression of myeloid cell activation - a continuing puzzle. Immunology 113: 281-292, 2004.
12. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG and Dayer JM: IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 96: 2304-2310, 1995.
13. Wang Y and Lou S: Direct protective effect of interleukin-10 on articular chondrocytes in vitro. Chin Med J (Engl) 114: 723-725, 2001.
14. Asadullah K, Sterry W and Volk HD: Interleukin-10 therapy - review of a new approach. Pharmacol Rev 55: 241-269, 2003.
15. Islam S, Kermode T, Sultana D, et al: Expression profile of protein tyrosine kinase genes in human osteoarthritis chondrocytes. Osteoarthritis Cartilage 9: 684-693, 2001.
16. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
17. Aida Y, Maeno M, Ito-Kato E, Suzuki N, Shiratsuchi H and Matsumura H: Effect of IL-1α on the expression of cartilage matrix proteins in human chondrosarcoma cell line OUMS-27. Life Sci 75: 3173-3184, 2004.
18. Saas J, Gebauer M, Jacobi C, Haag J, Takigawa M and Aigner T: The human chondrosarcoma HCS-2/8 cell line is responsive to BMP-7, but not to IL-1beta. Front Biosci 10: 2027-2035, 2005.
19. Shi J, Schmitt-Talbot E, Di Mattia DA and Dullea RG: The differential effects of IL-1 and TNF-α on proinflammatory cytokine and matrix metalloproteinase expression in human chondrosarcoma cells. Inflamm Res 53: 377-389, 2004.
20. Vincenti MP and Brinckerhoff CE: Early response genes induced in chondrocytes stimulated with the inflammatory cytokine interleukin-1beta. Arthritis Res 3: 381-388, 2001.
21. Liacini A, Sylvester J, Li WQ, Huang W, Dehnade F, Ahmad M and Zafarullah M: Induction of matrix metalloproteinase-13 gene expression by TNF-α is mediated by MAP kinases, AP-1, and NF-κB transcription factors in articular chondro-cytes. Exp Cell Res 288: 208-217, 2003.
22. Liacini A, Sylvester J, Li WQ and Zafarullah M: Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes. Arthritis Res Ther 7: R777-R783, 2005.
23. Tardif G, Dupuis M, Reboul P, Geng CS, Pelletier JP, Ranger P and Martel-Pelletier J: Identification and differential expression of human collagenase-3 mRNA species derived from internal deletion, alternative splicing, and different polyadenylation and transcription initiation sites. Osteoarthritis Cartilage 11: 524-537, 2003.
24. Young DA, Lakey RL, Pennington CJ, et al: Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 7: R503-R512, 2005.
25. Schaefer JF, Millham ML, De Crombrugghe B and Buckbinder L: FGF signaling antagonizes cytokine-mediated repression of Sox9 in SW1353 chondrosarcoma cells. Osteoarthritis Cartilage 11: 233-241, 2003.
26. Tsuda M, Takahashi S, Takahashi Y and Asahara H: Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem 278: 27224-27229, 2003. (Pubitemid 36876879)
27. Gebauer M, Saas J, Sohler F, et al: Comparison of the chondrosarcoma cell line SW1353 with primary human adult articular chondrocytes with regard to their gene expression profile and reactivity to IL-1β. Osteoarthritis Cartilage pp697-708, 2005.
28. Guerne PA, Carson DA and Lotz M: IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 144: 499-505, 1990.
29. Catterall JB, Carrere S, Koshy PJ, et al: Synergistic induction of matrix metalloproteinase 1 by interleukin-1α and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism. Arthritis Rheum 44: 2296-2310, 2001.
30. Rydziel S, Durant D and Canalis E: Platelet-derived growth factor induces collagenase 3 transcription in osteoblasts through the activator protein 1 complex. J Cell Physiol 184: 326-333, 2000.
31. Finbloom DS and Winestock KD: IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 155: 1079-1090, 1995.
32. Moore KW, De Waal MR, Coffman RL and O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765, 2001.
33. Wehinger J, Gouilleux F, Groner B, Finke J, Mertelsmann R and Weber-Nordt RM: IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett 394: 365-370, 1996.
34. Seifert M, Gruenberg BH, Sabat R, et al: Keratinocyte unresponsiveness towards interleukin-10: lack of specific binding due to deficient IL-10 receptor 1 expression. Exp Dermatol 12: 137-144, 2003.
35. Spencer SD, Di Marco F, Hooley J, et al: The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med 187: 571-578, 1998.
36. Wolk K, Witte E, Reineke U, et al: Is there an interaction between interleukin-10 and interleukin-22? Genes Immun 6: 8-18, 2005.
37. Müller-Ladner U, Evans CH, Franklin BN, Roberts CR, Gay RE, Robbins PD and Gay S: Gene transfer of cytokine inhibitors into human synovial fibroblasts in the SCID mouse model. Arthritis Rheum 42: 490-497, 1999.
38. Neumann E, Judex M, Kullmann F, et al: Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther 9: 1508-1519, 2002.
39. Joosten LA, Lubberts E, Durez P, Helsen MM, Jacobs MJ, Goldman M and van der Berg WB: Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum 40: 249-260, 1997.
40. Jorgensen C, Apparailly F, Couret I, Canovas F, Jacquet C and Sany J: Interleukin-4 and interleukin-10 are chondroprotective and decrease mononuclear cell recruitment in human rheumatoid synovium in vivo. Immunology 93: 518-523, 1998.
41. Verhoef CM, van Roon JA, Vianen ME, Bijlsma JW and Lafeber FP: Interleukin 10 (IL-10), not IL-4 or interferon-γ production, correlates with progression of joint destruction in rheumatoid arthritis. J Rheumatol 28: 1960-1966, 2001.